Oxford BioMedica PLC Total Liabilities

Latest as of June 2025: GBX183.59 Million GBX ≈ $22.34K USD

Oxford BioMedica PLC total liabilities. Based on the latest financial reports, Oxford BioMedica PLC (OXB) has total liabilities worth GBX183.59 Million GBX (≈ $22.34K USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check financial resilience of Oxford BioMedica PLC to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Oxford BioMedica PLC (1996–2024)

Total liabilities of Oxford BioMedica PLC from 1996 to 2024. This chart illustrates how Oxford BioMedica PLC's total liabilities have evolved over time, based on quarterly financial data. Explore Oxford BioMedica PLC (OXB) investment intensity to see how much of total assets are deployed in long-term investments.

Oxford BioMedica PLC Competitors by Total Liabilities

The table below lists competitors of Oxford BioMedica PLC ranked by their total liabilities.

Company	Country	Total Liabilities
Stavely Minerals Ltd AU:SVY	Australia	AU$417.11K
STO Co. Ltd KQ:098660	Korea	₩54.54 Billion
Melbana Energy Ltd AU:MAY	Australia	AU$24.24 Million
Miraculum SA WAR:MIR	Poland	zł29.04 Million
Impact Minerals Ltd AU:IPT	Australia	AU$690.13K
A.G.Barr PLC LSE:BAG	UK	GBX168.60 Million
Strategic Energy Resources Ltd AU:SER	Australia	AU$1.16 Million
Artemis Resources Ltd AU:ARV	Australia	AU$4.19 Million

Liability Composition Analysis (1996–2024)

This chart breaks down Oxford BioMedica PLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see OXB asset base.

Liquidity & Leverage Metrics

Oxford BioMedica PLC Total Liabilities Ratios Explained

Oxford BioMedica PLC total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	1.89	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	5.61	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.85	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Oxford BioMedica PLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Oxford BioMedica PLC (1996–2024)

The table below shows the annual total liabilities of Oxford BioMedica PLC from 1996 to 2024.

Year	Total Liabilities	Change
2024-12-31	GBX171.16 Million ≈ $20.82K	-1.92%
2023-12-31	GBX174.51 Million ≈ $21.23K	-22.09%
2022-12-31	GBX223.99 Million ≈ $27.25K	+348.95%
2021-12-31	GBX49.89 Million ≈ $6.07K	-29.91%
2020-12-31	GBX71.18 Million ≈ $8.66K	+50.50%
2019-12-31	GBX47.30 Million ≈ $5.75K	-39.10%
2018-12-31	GBX77.66 Million ≈ $9.45K	+31.06%
2017-12-31	GBX59.26 Million ≈ $7.21K	+33.68%
2016-12-31	GBX44.33 Million ≈ $5.39K	+8.23%
2015-12-31	GBX40.96 Million ≈ $4.98K	+280.43%
2014-12-31	GBX10.77 Million ≈ $1.31K	+126.84%
2013-12-31	GBX4.75 Million ≈ $577.45	-0.71%
2012-12-31	GBX4.78 Million ≈ $581.59	-42.58%
2011-12-31	GBX8.32 Million ≈ $1.01K	-40.71%
2010-12-31	GBX14.04 Million ≈ $1.71K	-38.88%
2009-12-31	GBX22.97 Million ≈ $2.80K	+15.73%
2008-12-31	GBX19.85 Million ≈ $2.42K	-32.09%
2007-12-31	GBX29.23 Million ≈ $3.56K	+436.53%
2006-12-31	GBX5.45 Million ≈ $662.86	+106.29%
2005-12-31	GBX2.64 Million ≈ $321.33	+19.77%
2004-12-31	GBX2.21 Million ≈ $268.28	+46.90%
2003-12-31	GBX1.50 Million ≈ $182.63	+19.13%
2002-12-31	GBX1.26 Million ≈ $153.31	-28.25%
2001-12-31	GBX1.76 Million ≈ $213.65	+31.04%
2000-12-31	GBX1.34 Million ≈ $163.04	+67.29%
1999-12-31	GBX801.00K ≈ $97.46	+66.88%
1998-12-31	GBX480.00K ≈ $58.40	+8.84%
1997-12-31	GBX441.00K ≈ $53.66	+250.00%
1996-12-31	GBX126.00K ≈ $15.33	0.00%
1996-09-30	GBX126.00K ≈ $15.33	--

About Oxford BioMedica PLC

LSE:OXB UK Biotechnology

Market Cap

$8.02 Million

GBX65.93 Billion GBX

Market Cap Rank

#27446 Global

#388 in UK

Share Price

GBX546.00

Change (1 day)

-0.73%

52-Week Range

GBX424.00 - GBX913.00

All Time High

GBX1634.00